If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ANZATAX paclitaxel 150mg/25mL injection vial AUST R: 50577Active ingredients:
paclitaxel
Dosage form: Injection, concentrated
Sponsor: Pfizer Australia Pty Ltd
Phone: 1800-675-229
|
From 12 Oct 2026 to 08 Jan 2027
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Other strengths are available.
|
Nab-PACLITAXEL JUNO Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial AUST R: 328527Active ingredients:
paclitaxel
Dosage form: Injection, powder for
Sponsor: Cipla Australia Pty Ltd
Phone: 0396964413
|
From 05 Feb 2026 to 08 Jan 2027
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: An alternative brand is available.
|
PACLITAXEL ACCORD paclitaxel 300 mg/50 mL concentrated injection vial AUST R: 219556Active ingredients:
paclitaxel
Dosage form: Injection, concentrated
Sponsor: Accord Healthcare Pty Ltd
Phone: 1800 222 673
|
From 10 Nov 2026 to 30 Nov 2026
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in consumer demand
Management action: An alternative brand is available.
|
ANZATAX paclitaxel 100mg/16.7mL injection vial AUST R: 106458Active ingredients:
paclitaxel
Dosage form: Injection, concentrated
Sponsor: Pfizer Australia Pty Ltd
Phone: 1800 675 229
|
From 01 Mar 2027 to 30 Apr 2027
|
Shortage status: Anticipated
Availability: Available
Reason: Manufacturing
Management action: An alternative strength is available.
|
ANZATAX paclitaxel 300mg/50mL injection vial AUST R: 91256Active ingredients:
paclitaxel
Dosage form: Injection, concentrated
Sponsor: Pfizer Australia Pty Ltd
Phone: 1800-675-229
|
From 21 Dec 2026 to 08 Jan 2027
|
Shortage status: Anticipated
Availability: Available
Reason: Manufacturing
Management action: An alternative brand is available.
|
PACLITAXEL EBEWE paclitaxel 300 mg/50 mL concentrated injection vial AUST R: 98551Active ingredients:
paclitaxel
Dosage form: Injection, concentrated
Sponsor: Sandoz Pty Ltd
Phone: 180072636
|
Deletion from market:
10 Apr 2026
|
Shortage status: Discontinued
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
Management action: Alternative brands are available.
|